Saturday, November 29, 2014 1:05:53 AM
Purpose of the trial:
- To evaluate whether the Scaffold is safe and feasible for the treatment of complete functional spinal cord injury as determined by no degradation in paralysis level or sensory motor neurological function beyond that typically seen in the AIS A subject.
- To gather preliminary evidence of clinical effectiveness of the Scaffold, including improvement of ASIA Impairment Scale, sensory scores, motor scores, bladder and bowel function, neurological tests, and The Spinal Cord Independence Measure III.
http://clinicaltrials.gov/ct2/show/study/NCT02138110
As always, in my opinion only. Do your own due diligence!
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM